Breaks Categories: News

WednesdaySep 21, 2022 1:59 pm

NetworkNewsBreaks – EF Hutton Announces Inaugural Global Conference

EF Hutton will be hosting its first-ever EF Hutton Global Conference. The two-day event will showcase dynamic public and private companies that come from an array of sectors. The conference will feature an intimate one-on-one conference with no generation presentations. The invitation-only gathering will bring together key executives from some 150 public and private companies; these leaders will share their stories to an extensive virtual audience that includes institutional investors, high-net-worth individuals, corporate clients and limited members of the press. In addition, the conference provides opportunities for investors and executives to interact with each other, with investors being able to…

Continue Reading

WednesdaySep 21, 2022 1:32 pm

NetworkNewsBreaks – Coinbase Global Inc. (NASDAQ: COIN) Enters Strategic Partnership to Advance Crypto ETP Space in Canada

Coinbase (NASDAQ: COIN), together with 3iQ Digital Asset Management (“3iQ”), announced a new partnership aimed at expanding the exchange-traded product (“ETP”) ecosystem for digital assets in Canada and generating new interest from the investment community. Under the collaboration, Coinbase and Tetra will serve as custodians for 3iQ’s ETPs, including the 3iQ CoinShares Bitcoin ETF (TSX: BTCQ) and the Bitcoin Fund (TSX: QBTC), which became North America’s first bitcoin ETP when it launched in April 2020. They will also serve as custodians for 3iQ CoinShares Ether ETF (TSX: ETHQ) and the Ether Fund (TSX: QETH). In addition, 3iQ has selected Coinbase…

Continue Reading

WednesdaySep 21, 2022 1:13 pm

NetworkNewsBreaks — Mullen Automotive Inc.’s (NASDAQ: MULN) Bollinger Motors Teams Up with Wabash to Develop New Body on Electric Chassis

Mullen Automotive (NASDAQ: MULN), through its recent majority acquisition, Bollinger Motors Inc., is partnering with Wabash, a leading truck body and trailer manufacturer. The partnership will focus on developing a stronger, lighter, refrigerated truck body on an electric chassis. The plan is to seamlessly integrate Bollinger’s Class 4 electric chassis cab with Wabash’s lightweight composite technology, EcoNex(TM), which will be used in truck bodies and trailers. According to the announcement, the exclusive EcoNex technology’s composite material is lighter and more durable and thermally efficient than other commercial products. With that in mind, the new offering will feature weight savings because…

Continue Reading

WednesdaySep 21, 2022 12:13 pm

NetworkNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Participation in Upcoming Scientific and Investor Conferences

Cybin (NYSE American: CYBN) (NEO: CYBN) is a biotechnology company focused on progressing Psychedelics to Therapeutics(TM). The company today announced its participation in upcoming conferences taking place in September and October 2022. The company’s CEO Doug Drysdale participated in a panel discussion titled “Trials to Treatments” at the Interdisciplinary Conference on Psychedelic Research, Psychedelic Science, Ethics & Business Event in Haarlem, Amsterdam. The announcement includes further details on additional conferences and the participation schedule for Drysdale and additional members of Cybin’s management team in panel discussions and presentations. The additional events include the Interdisciplinary Conference on Psychedelic Research, Sept. 22-24,…

Continue Reading

WednesdaySep 21, 2022 11:51 am

NetworkNewsBreaks — GATC Health Corporation Releases Report on Recent Analysis Showing New Platform Performs 11x Better Than Industry Standard

GATC Health, a science and technology company revolutionizing drug discovery and disease prediction using its proprietary upgraded version 2.0 of its drug-discovery artificial intelligence (“AI”) platform, is reporting on its recently completed analysis. According to the release, the company’s upgraded drug-discovery platform forecasts drug-candidate success rate with 88% accuracy; the platform also predicts drug-failure rates with 84% accuracy. Biopharma companies can potentially save billions of dollars using the new offering, the company observed. The report provides further validation of the accuracy of GATC Health’s newly launched platform, which is designed to study and predict the biological success of drug compounds.…

Continue Reading

WednesdaySep 21, 2022 11:45 am

NetworkNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) CEO Discusses News in Latest Power Play by The Market Herald Release

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, was featured in the most recent Power Play by The Market Herald report. Eloro Resources executive vice president of exploration Bill Pearson talked with host Sabrina Cuthbert about the company’s most recent news about the high-grade assays reported from its Iska Iska project in Bolivia. After discussing the results of the 21 diamond drill holes from the project, Pearson noted that the company is continuing to expand its Santa Barbara high-grade feeder zone…

Continue Reading

WednesdaySep 21, 2022 11:39 am

NetworkNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Closes on Recently Announced $20M Public Offering

Aditxt Inc. (NASDAQ: ADTX), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, has closed on its recent public offering. The offering was comprised of 3,333,333 shares of common stock or common stock equivalents; the offering also included warrants to purchase up to 3,333,333 shares of common stock. The combined offering price to the public was $6 per share and associated warrant, with the warrants, which are exercisable upon being issued, having an exercise price of $6 per share. H.C. Wainwright & Co. acted as the exclusive placement agent for the offering, which resulted…

Continue Reading

WednesdaySep 21, 2022 11:27 am

NetworkNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) to Take the Spotlight with a Robot Show in Sterling, Virginia

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced that its Robot Roadshow will land at 22895 Ladbrook Drive in Sterling, Virginia, on Sept. 20-21, 2022. The Robot Roadshow is an engaging experiential event designed to grab attention, forge direct connections with potential clients, and strike up conversations in a compelling fashion. The announcement reads, “The Robot Roadshow has made 56 landings in 22 states and Washington, D.C., to date. Knightscope’s crime-fighting robots tour the U.S. in a space-age, NASA-like ‘pod’ allowing attendees to experience all the technology that is enabling…

Continue Reading

TuesdaySep 20, 2022 3:20 pm

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Releases New Video Exploring Its Technologies, Progress of AIMIGo(TM) Device

HeartBeam (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere. The company today announced that, in conjunction with its upcoming virtual roadshow webinar taking place at 4:30 p.m. ET on Tuesday, Sept. 20, 2022, it has released a new video that takes viewers behind the scenes for a featured look at the HeartBeam AIMIGo technology. “This new video provides a compelling overview and explanation of our technologies and highlights our continued progress toward making the AIMIGo device available for remote heart attack detection,” said Branislav Vajdic,…

Continue Reading

TuesdaySep 20, 2022 2:28 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting Hypertension Drug Market with Proprietary Drug-Delivery Method

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is focused on establishing a stronghold in the $28 billion hypertension drug market. The company’s exclusive therapeutic, DehydraTECH-CBD, has shown exciting potential as an alternative to traditional cannabidiol (“CBD”) dosing methods; the proprietary treatment may offer improved and more rapid absorption of drugs into the bloodstream and brain. According to the announcement, only one FDA-approved CBD drug is currently available on the market; that drug is for pediatric epilepsy. Lexaria is working to offer the second-ever, FDA-approved CBD therapeutic, designed to treat hypertension. The market for the treatment is tremendous,…

Continue Reading